ORIGINAL ARTICLE
Year : 2019 | Volume
: 5 | Issue : 2 | Page : 158--162
Ultrasound and hormonal (Thyroid stimulating hormone and prolactin) evaluation in mastalgia
Syed Nazneen1, Anjili Kumari1, Jyotsna Kashyap2, Anita Kumari1, Jaya Kumari1, Pratibha Kumari1, Sangeeta Pankaj3
1 Senior Resident, Gynecological Oncology, Dept. of Gynecological Oncology, IGIMS, Patna, Bihar, India
2 Consultant Gynecology, Dept. of Gynecological Oncology, IGIMS, Patna, Bihar, India
3 Professor & Head, Dept. of Gynecological Oncology, IGIMS, Patna, Bihar, India
Correspondence Address:
Sangeeta Pankaj
Professor & Head, Gynecological Oncology, IGIMS, Patna
India
Background: Breast pain (mastalgia) is a significant issue within the general population warranting increased investigation, awareness, and treatment. This study is being performed to study role of ultrasound and to evaluate Thyroid Stimulating Hormone (TSH) and Prolactin levels in our patient population with the complaint of mastalgia .
Methods: This was a prospective observational study in which 100 patients of mastalgia were included. Pregnant and lactating women, known cases of breast cancer, patients with palpable breast lumps and those with breast abscesses, women on antidepressants, antihypertensives and oral contraceptive pills were excluded from the study. Ultrasound findings and serum TSH and Prolactin levels were assessed in all patients included in the study. Those with hypothyroidism and hyperprolactinemia were treated with thyroxine and bromocryptine respectively and the response to treatment observed.
Results: Mean age of women in study was 35.37 years. Most of them (90%) were multiparous. Ultrasound findings included 57% normal results, 32% benign cystic disease of the breast, 6% small fibroadenomas, 4% duct ectasia and 1 case of filariasis of breast. Out of 100, 18 women (18%) had hypothyroidism (TSH >5). 8 (8%) women in our study with mastalgia had elevated serum prolactin levels. Decrease in mastalgia in 15 women with hypothyroidism and in all women with hyperprolactinemia was observed after appropriate therapy.
Conclusion: Sonological findings can be the baseline while starting the treatment in patients with mastalgia. Our study strengthens the association of thyroid dysfunction and raised prolactin levels with mastalgia. Women with mastalgia should be screened for hypothyroidism and for raised serum prolactin levels because simple correction of these changes may result in clinical improvement.
How to cite this article:
Nazneen S, Kumari A, Kashyap J, Kumari A, Kumari J, Kumari P, Pankaj S. Ultrasound and hormonal (Thyroid stimulating hormone and prolactin) evaluation in mastalgia.J Indira Gandhi Inst Med Sci 2019;5:158-162
|
How to cite this URL:
Nazneen S, Kumari A, Kashyap J, Kumari A, Kumari J, Kumari P, Pankaj S. Ultrasound and hormonal (Thyroid stimulating hormone and prolactin) evaluation in mastalgia. J Indira Gandhi Inst Med Sci [serial online] 2019 [cited 2023 Mar 21 ];5:158-162
Available from: http://www.jigims.co.in/article.asp?issn=2394-9031;year=2019;volume=5;issue=2;spage=158;epage=162;aulast=Nazneen;type=0 |
|
